Mega Lifesciences Public Co. Ltd. (MEGA) Stock Price & Analysis
MEGA Stock Chart & Stats
- Day’s Range
- THB 34.75 - THB 35.50
- 52-Week Range
- THB 29.00 - THB 40.00
- Previous Close
- THB 35.50
- Volume
- N/A
- Average Volume (3M)
- 1.04M
- Market Cap
- THB 30.73B
- Enterprise Value
- THB 28.71B
- Total Cash (Recent Filing)
- THB 4.02B
- Total Debt (Recent Filing)
- THB 694.75M
- Price to Earnings (P/E)
- 14.0
- Beta
- 0.61
- Next Earnings
- Nov 16, 2026 (Est.)
- EPS Estimate
- 0.64
- Last Dividend Ex-Date
- Aug 26, 2026
- Dividend Yield
- 4.68%
MEGA FAQ
What was Mega Lifesciences Public Co. Ltd.’s price range in the past 12 months?
What is Mega Lifesciences Public Co. Ltd.’s market cap?
When is Mega Lifesciences Public Co. Ltd.’s upcoming earnings report date?
How were Mega Lifesciences Public Co. Ltd.’s earnings last quarter?
Is Mega Lifesciences Public Co. Ltd. overvalued?
Does Mega Lifesciences Public Co. Ltd. pay dividends?
What is Mega Lifesciences Public Co. Ltd.’s EPS estimate?
How many shares outstanding does Mega Lifesciences Public Co. Ltd. have?
What happened to Mega Lifesciences Public Co. Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Mega Lifesciences Public Co. Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Mega Lifesciences Public Co. Ltd.
Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, operates as a comprehensive pharmaceutical and wellness enterprise. Its primary activities encompass the development, promotion, and distribution of a broad spectrum of health-related products, including nutritional supplements, prescription medicines, over-the-counter (OTC) remedies, botanical solutions, vitamins, and everyday consumer goods. The company structures its operations across three main divisions: Brands, Distribution, and Original Equipment Manufacture. Mega Lifesciences offers an extensive array of complementary medicines targeting various health concerns such as bone and joint health, pediatric care, diabetes management, cardiovascular support, digestive and liver wellness, skin health, weight management, overall well-being, men's and women's specific needs, and sports nutrition. Its OTC portfolio addresses common issues like gastrointestinal discomfort and pain. Furthermore, the prescription drug division covers crucial therapeutic areas including iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain relief, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its proprietary product lines, the company also provides third-party logistical and marketing services. Additionally, Mega Lifesciences is involved in managing wellness centers and offers specialized services in software design, development, and related technological solutions. The company maintains a significant global footprint, with operations spanning the Asia Pacific region, the Middle East, Africa, and the Commonwealth of Independent States.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Vivek Dhawan
- Employees
- 900
- Website
- www.megawecare.com
- Address
- 909, Ample Tower, Bangkok, BM, 10260, TH
Mega Lifesciences Public Co. Ltd. (MEGA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 5 | 3 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 11 | 0 | 1 |
